BIOGEN INC. Income Tax Expense 2007-2026 | BIIB
Beta
What is income tax expense?
Income tax expense is the total amount of income taxes a company owes to federal, state, and foreign governments.
What is BIOGEN INC.'s current income tax expense?
BIOGEN INC. (BIIB) annual income tax expense for 2025 was $263.6M, a 3.73% decline from 2024. BIOGEN INC. income tax expense for the quarter ending March 31, 2026 was $58.2M.
What was BIOGEN INC.'s income tax expense in 2024?
BIOGEN INC. annual income tax expense for 2024 was $273.8M, a 102.37% increase from 2023.
What was BIOGEN INC.'s income tax expense in 2023?
BIOGEN INC. annual income tax expense for 2023 was $135.3M, a 78.62% decline from 2022.
What is BIOGEN INC.'s 5-year income tax expense CAGR?
BIOGEN INC. income tax expense grew at a compound annual growth rate (CAGR) of 23.29% from FY2020 to FY2025, going from $992.3M to $263.6M over 5 years.
Income Tax Expense History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR-23.3%
FY2020
$992.3M
→
FY2025
$263.6M
07080910111213141516171819202122232425
5 years selected
Income Tax Expense History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $263.6M | -3.7% | 10-K |
| FY2024 | $273.8M | +102.4% | 10-K |
| FY2023 | $135.3M | -78.6% | 10-K |
| FY2022 | $632.8M | +1105.3% | 10-K |
| FY2021 | $52.5M | -94.7% | 10-K |
| FY2020 | $992.3M | -14.3% | 10-K |
| FY2019 | $1.16B | -18.8% | 10-K |
| FY2018 | $1.43B | -42.0% | 10-K |
| FY2017 | $2.46B | +98.7% | 10-K |
| FY2016 | $1.24B | +6.5% | 10-K |
| FY2015 | $1.16B | +17.3% | 10-K |
| FY2014 | $989.9M | +64.7% | 10-K |
| FY2013 | $601.0M | +27.7% | 10-K |
| FY2012 | $470.6M | +5.9% | 10-K |
| FY2011 | $444.5M | +34.2% | 10-K |
| FY2010 | $331.3M | -6.8% | 10-K |
| FY2009 | $355.6M | -2.8% | 10-K |
| FY2008 | $365.8M | +34.3% | 10-K |
| FY2007 | $272.4M | - | 10-K |
Company: BIOGEN INC.Ticker: BIIBSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →